Interferonopathies are disorders of the interferone signaling. Their manifestation is mainly immunodeficiencies and autoinflammatory phenomena, but also dysmorphisms are common.
| 1. |
Dale RC et al. (2000) Familial systemic lupus erythematosus and congenital infection-like syndrome.
|
| 2. |
Singleton EB et al. (1973) An unusual syndrome of widened medullary cavities of the metacarpals and phalanges, aortic calcification and abnormal dentition.
|
| 3. |
Gay BB et al. (1976) A syndrome of widened medullary cavities of bone, aortic calcification, abnormal dentition, and muscular weakness (the Singleton-Merten syndrome).
|
| 4. |
None (1888) Harveian Lectures on Lupus.
|
| 5. |
None (2005) The Gordon Wilson Lecture: The clinical legacy of Jonathan Hutchinson (1828-1913): syndromology and dysmorphology meet genomics.
|
| 6. |
None (1952) The clinical observations of Jonathan Hutchinson.
|
| 7. |
Weston WL et al. () Childhood pernio and cryoproteins.
|
| 8. |
Crow YJ et al. (2009) Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.
|
| 9. |
None (2008) Aicardi-Goutières syndrome (AGS).
|
| 10. |
Lanzi G et al. (2005) The natural history of Aicardi-Goutières syndrome: follow-up of 11 Italian patients.
|
| 11. |
Crow YJ et al. (2004) Congenital glaucoma and brain stem atrophy as features of Aicardi-Goutières syndrome.
|
| 12. |
Crow YJ et al. (2003) Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism.
|
| 13. |
Feigenbaum A et al. (2013) Singleton-Merten syndrome: an autosomal dominant disorder with variable expression.
|
| 14. |
Aicardi J et al. (2000) Systemic lupus erythematosus or Aicardi-Goutières syndrome?
|
| 15. |
Crow YJ et al. (2000) Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21.
|
| 16. |
Goutières F et al. (1998) Aicardi-Goutières syndrome: an update and results of interferon-alpha studies.
|
| 17. |
Akwa Y et al. (1998) Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration.
|
| 18. |
McEntagart M et al. (1998) Aicardi-Goutières syndrome: an expanding phenotype.
|
| 20. |
Raymond AA et al. (1996) Brain calcification in patients with cerebral lupus.
|
| 21. |
Tolmie JL et al. (1995) The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis).
|
| 22. |
Aicardi J et al. (1984) A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.
|
| 23. |
Babbitt DP et al. (1969) Idiopathic familial cerebrovascular ferrocalcinosis (Fahr's disease) and review of differential diagnosis of intracranial calcification in children.
|
| 24. |
Giroud M et al. (1986) A case of progressive familial encephalopathy in infancy with calcification of the basal ganglia and chronic cerebrospinal fluid lymphocytosis.
|
| 25. |
Schorr S et al. (1976) Spondyloenchondrodysplasia. Enchondromatomosis with severe platyspondyly in two brothers.
|
| 26. |
Pansuriya TC et al. (2010) Enchondromatosis: insights on the different subtypes.
|
| 28. |
Kulkarni ML et al. (2007) A syndrome of immunodeficiency, autoimmunity, and spondylometaphyseal dysplasia.
|
| 29. |
Bhargava R et al. (2005) Autosomal dominant inheritance of spondyloenchondrodysplasia.
|
| 30. |
Tüysüz B et al. (2004) Spondyloenchondrodysplasia: clinical variability in three cases.
|
| 31. |
Uhlmann D et al. (1998) Spondyloenchondrodysplasia: several phenotypes--the same syndrome.
|
| 32. |
Sauvegrain J et al. () [Multiple chondroma affecting the spine: spondylo-enchondroplasia and other forms (author's transl)].
|
| 33. |
Chagnon S et al. (1985) [Spondylo-enchondrodysplasia].
|
| 34. |
Menger H et al. (1989) Spondyloenchondrodysplasia.
|
| 35. |
Halal F et al. (1991) Generalized enchondromatosis in a boy with only platyspondyly in the father.
|
| 36. |
Robinson D et al. (1991) Spondyloenchondrodysplasia. A rare cause of short-trunk syndrome.
|
| 37. |
Mehta L et al. (1986) Familial calcification of the basal ganglia with cerebrospinal fluid pleocytosis.
|
| 38. |
Spranger J et al. (1978) Two peculiar types of enchondromatosis.
|
| 39. |
Gustavson KH et al. (1978) Spondylometaphyseal dysplasia in two sibs of normal parents.
|
| 40. |
Mateen FJ et al. (2010) Evolution of a tumor-like lesion in cerebroretinal vasculopathy and TREX1 mutation.
|
| 41. |
Cohn AC et al. (2005) Novel ophthalmological features in hereditary endotheliopathy with retinopathy, nephropathy and stroke syndrome.
|
| 42. |
Siveke JT et al. (2003) Evidence for systemic manifestations in cerebroretinal vasculopathy.
|
| 44. |
Weil S et al. (1999) Cerebroretinal vasculopathy mimicking a brain tumor: a case of a rare hereditary syndrome.
|
| 45. |
Terwindt GM et al. (1998) Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon.
|
| 46. |
Gutmann DH et al. (1989) Hereditary retinal vasculopathy with cerebral white matter lesions.
|
| 47. |
Egritas O et al. (2009) Tricho-hepato-enteric syndrome presenting with mild colitis.
|
| 48. |
Girschick H et al. (2015) Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene.
|
| 49. |
Jen J et al. (1997) Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS).
|
| 50. |
Grand MG et al. (1988) Cerebroretinal vasculopathy. A new hereditary syndrome.
|
| 51. |
Storimans CW et al. () A new autosomal dominant vascular retinopathy syndrome.
|
| 52. |
Rice GI et al. (2013) Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in Aicardi-Goutières syndrome.
|
| 53. |
Rice G et al. (2007) Clinical and molecular phenotype of Aicardi-Goutieres syndrome.
|
| 54. |
Crow YJ et al. (2006) Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection.
|
| 55. |
Sanchis A et al. (2005) Genetic syndromes mimic congenital infections.
|
| 56. |
Fabre A et al. (2012) SKIV2L mutations cause syndromic diarrhea, or trichohepatoenteric syndrome.
|
| 57. |
Briggs TA et al. (2016) Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey.
|
| 58. |
Bilginer Y et al. (2016) Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature.
|
| 59. |
de Bruin C et al. (2016) Severe Short Stature in Two Siblings as the Presenting Sign of ACP5 Deficiency.
|
| 60. |
Crow YJ et al. (2006) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus.
|
| 61. |
Briggs TA et al. (2011) Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature.
|
| 62. |
Lausch E et al. (2011) Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.
|
| 63. |
Navarro V et al. (2008) Two further cases of spondyloenchondrodysplasia (SPENCD) with immune dysregulation.
|
| 64. |
Renella R et al. (2006) Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: clinical and radiographic delineation of a pleiotropic disorder.
|
| 65. |
None (1958) [A case of infantile generalized lupus erythematosus with unusual bone changes].
|
| 66. |
Roifman CM et al. (2003) A novel syndrome of combined immunodeficiency, autoimmunity and spondylometaphyseal dysplasia.
|
| 67. |
Frydman M et al. (1990) Possible heterogeneity in spondyloenchondrodysplasia: quadriparesis, basal ganglia calcifications, and chondrocyte inclusions.
|
| 68. |
Zhang X et al. (2015) Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.
|
| 69. |
Bogunovic D et al. (2012) Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.
|
| 70. |
Crow YJ et al. (2014) Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia.
|
| 71. |
Livingston JH et al. (2014) A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1.
|
| 72. |
Leshinsky-Silver E et al. (2011) A large homozygous deletion in the SAMHD1 gene causes atypical Aicardi-Goutiéres syndrome associated with mtDNA deletions.
|
| 73. |
Black DN et al. (1988) Encephalitis among Cree children in northern Quebec.
|
| 74. |
Ali M et al. (2006) A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21.
|
| 75. |
Vogt J et al. (2013) Striking intrafamilial phenotypic variability in Aicardi-Goutières syndrome associated with the recurrent Asian founder mutation in RNASEH2C.
|
| 76. |
Jang MA et al. (2015) Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome.
|
| 77. |
Meuwissen ME et al. (2016) Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome.
|
| 78. |
Knoblauch H et al. (2003) Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome).
|
| 79. |
Rutsch F et al. (2015) A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome.
|
| 80. |
Oda H et al. (2014) Aicardi-Goutières syndrome is caused by IFIH1 mutations.
|
| 81. |
Rice GI et al. (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.
|
| 82. |
Valverde I et al. (2010) Singleton-merten syndrome and impaired cardiac function.
|
| 83. |
Ravenscroft JC et al. (2011) Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus.
|
| 84. |
Rice GI et al. (2012) Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
|
| 85. |
Dale RC et al. (2010) Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures.
|
| 86. |
Rice GI et al. (2009) Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response.
|
| 87. |
Adang LA et al. (2018) Aicardi goutières syndrome is associated with pulmonary hypertension.
|
| 88. |
Cuadrado E et al. (2015) Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release.
|
| 89. |
Haaxma CA et al. (2010) A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi-Goutières syndrome.
|
| 90. |
Richards A et al. (2007) C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.
|
| 91. |
Lee-Kirsch MA et al. (2007) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
|
| 92. |
Lee-Kirsch MA et al. (2007) A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus.
|
| 93. |
Rice G et al. (2007) Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.
|
| 94. |
Lee-Kirsch MA et al. (2006) Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p.
|